Dopamine transporter function differences between male and female CD-1 mice

被引:52
作者
Bhatt, SD [1 ]
Dluzen, DE [1 ]
机构
[1] Northeastern Ohio Univ Coll Med & Pharm, Coll Med, Dept Anat, Rootstown, OH 44272 USA
关键词
methamphetamine; neurotoxicity; sex differences; nomifensine; neuroprotection; Parkinson's disease;
D O I
10.1016/j.brainres.2004.12.013
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
It has been reported that male mice are more susceptible to the neurotoxic effects of methamphetamine (MA) upon the nigrostriatal dopaminergic (NSDA) system. Since MA utilizes the dopamine transporter (DAT) to exert its effects, in the present study, we tested for differences in the dynamics of DAT function between male and female mice as an approach to understand some of the bases for this sex difference in MA-induced NSDA neurotoxicity. To accomplish this goal, in Experiment 1, the amount of dopamine (DA) obtained following DA infusion into the superfused striatal tissue fragments of male and female mice was measured while in Experiment 2 responses to the DA uptake blocker, nomifiensine (NMF), were assessed in these preparations. The differences obtained to these treatments demonstrate that marked differences in DA transporter activity exist between male and female mice. When combining the DA and DOPAC measures from these two experiments, the data suggest that the female mice show a more active and efficient recovery and vesicular packaging of extracellular DA. These findings have important implications for sex differences in NSDA functions and responses to neurotoxins which enter the neurons via the DAT. (c) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:188 / 195
页数:8
相关论文
共 59 条
  • [31] MANIPULATING THE DOPAMINERGIC SYSTEM IN PARKINSONS-DISEASE
    LANG, AE
    [J]. PHARMACOLOGY & THERAPEUTICS, 1987, 32 (01) : 51 - 76
  • [32] Effect of age and gender on dopamine transporter imaging with [123I]FP-CIT SPET in healthy volunteers
    Lavalaye, J
    Booij, J
    Reneman, L
    Habraken, JBA
    van Royen, EA
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 2000, 27 (07) : 867 - 869
  • [33] INHIBITION OF SYNAPTOSOMAL HIGH-AFFINITY UPTAKE OF DOPAMINE AND SEROTONIN BY ESTROGEN AGONISTS AND ANTAGONISTS
    MICHEL, MC
    ROTHER, A
    HIEMKE, C
    GHRAF, R
    [J]. BIOCHEMICAL PHARMACOLOGY, 1987, 36 (19) : 3175 - 3180
  • [34] The impact of gender and estrogen on striatal dopaminergic neurotoxicity
    Miller, DB
    Ali, SF
    O'Callaghan, JP
    Laws, SC
    [J]. NEUROCHEMISTRY OF DRUGS OF ABUSE: COCAINE, IBOGAINE, AND SUBSTITUTED AMPHETAMINES, 1998, 844 : 153 - 165
  • [35] Dopamine transporters and neuronal injury
    Miller, GW
    Gainetdinov, RR
    Levey, AI
    Caron, MG
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 1999, 20 (10) : 424 - 429
  • [36] PREVALENCE OF MOVEMENT-DISORDERS IN ELDERLY COMMUNITY RESIDENTS
    MOGHAL, S
    RAJPUT, AH
    DARCY, C
    RAJPUT, R
    [J]. NEUROEPIDEMIOLOGY, 1994, 13 (04) : 175 - 178
  • [37] EFFECT OF CHRONIC ESTRADIOL AND PROGESTERONE TREATMENTS OF OVARIECTOMIZED RATS ON BRAIN DOPAMINE UPTAKE SITES
    MORISSETTE, M
    DIPAOLO, T
    [J]. JOURNAL OF NEUROCHEMISTRY, 1993, 60 (05) : 1876 - 1883
  • [38] EFFECT OF ESTRADIOL AND PROGESTERONE ON RAT STRIATAL DOPAMINE UPTAKE SITES
    MORISSETTE, M
    BIRON, D
    DIPAOLO, T
    [J]. BRAIN RESEARCH BULLETIN, 1990, 25 (03) : 419 - 422
  • [39] SEX AND ESTROUS-CYCLE VARIATIONS OF RAT STRIATAL DOPAMINE UPTAKE SITES
    MORISSETTE, M
    DIPAOLO, T
    [J]. NEUROENDOCRINOLOGY, 1993, 58 (01) : 16 - 22
  • [40] UPTAKE OF THE NEUROTOXIN, 4-METHYLPHENYLPYRIDINIUM, INTO CHROMAFFIN GRANULES AND SYNAPTIC VESICLES - A PROTON GRADIENT DRIVES ITS UPTAKE THROUGH MONOAMINE TRANSPORTER
    MORIYAMA, Y
    AMAKATSU, K
    FUTAI, M
    [J]. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1993, 305 (02) : 271 - 277